EQUITY RESEARCH MEMO

Lygos

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)70/100

Lygos is a privately held specialty chemical company headquartered in Berkeley, California, founded in 2010. The company leverages synthetic biology and metabolic engineering to develop high-performance, biodegradable chemical solutions. Its product portfolio targets sustainable alternatives for industries such as agronomy, home care, hygiene, personal care, and water treatment. Lygos emphasizes a commercial model centered on scaling through manufacturing partnerships, aiming to deliver measurable performance and economic benefits. Despite being a relatively mature private firm, the company remains lean with limited public disclosure; however, its focus on green chemistry positions it well in the growing bio-based chemicals market.

Upcoming Catalysts (preview)

  • TBDCommercial partnership for bio-based malonic acid75% success
  • TBDSeries C or later funding round60% success
  • TBDScale-up of manufacturing with existing partners80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)